Chapter 1 : INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models

Chapter 2 : EXECUTIVE SUMMARY
2.1. CXO Perspective

Chapter 3 : MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter 4 : JAPAN GENERIC DRUGS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Generic Prescription Medicines
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Super Generics
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Biosimilars
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country

Chapter 5 : JAPAN GENERIC DRUGS MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Cardiovascular Products
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Anti-Infective Drugs
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Anti-Arthritis Drugs
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Central Nervous System Drugs
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Anti-Cancer Drug
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Respiratory Products
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
5.8. Others
5.8.1. Key Market Trends, Growth Factors and Opportunities
5.8.2. Market Size and Forecast, By Region
5.8.3. Market Share Analysis, By Country

Chapter 6 : JAPAN GENERIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Overview
6.1.1 Market Size and Forecast, By Distribution Channel
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Pharmacies
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Private Clinics
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Drug Stores
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Retail Pharmacies
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Others
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country

Chapter 7 : JAPAN GENERIC DRUGS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By Distribution Channel
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S.
7.2.6.1 Market size and forecast, product type
7.2.6.2 Market size and forecast, application
7.2.6.3 Market size and forecast, distribution channel
7.2.7. Canada
7.2.7.1 Market size and forecast, product type
7.2.7.2 Market size and forecast, application
7.2.7.3 Market size and forecast, distribution channel
7.2.8. Mexico
7.2.8.1 Market size and forecast, product type
7.2.8.2 Market size and forecast, application
7.2.8.3 Market size and forecast, distribution channel
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By Distribution Channel
7.3.5. Market Size and Forecast, By Country
7.3.6. France
7.3.6.1 Market size and forecast, product type
7.3.6.2 Market size and forecast, application
7.3.6.3 Market size and forecast, distribution channel
7.3.7. Germany
7.3.7.1 Market size and forecast, product type
7.3.7.2 Market size and forecast, application
7.3.7.3 Market size and forecast, distribution channel
7.3.8. Italy
7.3.8.1 Market size and forecast, product type
7.3.8.2 Market size and forecast, application
7.3.8.3 Market size and forecast, distribution channel
7.3.9. Spain
7.3.9.1 Market size and forecast, product type
7.3.9.2 Market size and forecast, application
7.3.9.3 Market size and forecast, distribution channel
7.3.10. UK
7.3.10.1 Market size and forecast, product type
7.3.10.2 Market size and forecast, application
7.3.10.3 Market size and forecast, distribution channel
7.3.11. Russia
7.3.11.1 Market size and forecast, product type
7.3.11.2 Market size and forecast, application
7.3.11.3 Market size and forecast, distribution channel
7.3.12. Rest Of Europe
7.3.12.1 Market size and forecast, product type
7.3.12.2 Market size and forecast, application
7.3.12.3 Market size and forecast, distribution channel
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By Distribution Channel
7.4.5. Market Size and Forecast, By Country
7.4.6. China
7.4.6.1 Market size and forecast, product type
7.4.6.2 Market size and forecast, application
7.4.6.3 Market size and forecast, distribution channel
7.4.7. Japan
7.4.7.1 Market size and forecast, product type
7.4.7.2 Market size and forecast, application
7.4.7.3 Market size and forecast, distribution channel
7.4.8. India
7.4.8.1 Market size and forecast, product type
7.4.8.2 Market size and forecast, application
7.4.8.3 Market size and forecast, distribution channel
7.4.9. South Korea
7.4.9.1 Market size and forecast, product type
7.4.9.2 Market size and forecast, application
7.4.9.3 Market size and forecast, distribution channel
7.4.10. Australia
7.4.10.1 Market size and forecast, product type
7.4.10.2 Market size and forecast, application
7.4.10.3 Market size and forecast, distribution channel
7.4.11. Thailand
7.4.11.1 Market size and forecast, product type
7.4.11.2 Market size and forecast, application
7.4.11.3 Market size and forecast, distribution channel
7.4.12. Malaysia
7.4.12.1 Market size and forecast, product type
7.4.12.2 Market size and forecast, application
7.4.12.3 Market size and forecast, distribution channel
7.4.13. Indonesia
7.4.13.1 Market size and forecast, product type
7.4.13.2 Market size and forecast, application
7.4.13.3 Market size and forecast, distribution channel
7.4.14. Rest of Asia Pacific
7.4.14.1 Market size and forecast, product type
7.4.14.2 Market size and forecast, application
7.4.14.3 Market size and forecast, distribution channel
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By Distribution Channel
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil
7.5.6.1 Market size and forecast, product type
7.5.6.2 Market size and forecast, application
7.5.6.3 Market size and forecast, distribution channel
7.5.7. South Africa
7.5.7.1 Market size and forecast, product type
7.5.7.2 Market size and forecast, application
7.5.7.3 Market size and forecast, distribution channel
7.5.8. Saudi Arabia
7.5.8.1 Market size and forecast, product type
7.5.8.2 Market size and forecast, application
7.5.8.3 Market size and forecast, distribution channel
7.5.9. UAE
7.5.9.1 Market size and forecast, product type
7.5.9.2 Market size and forecast, application
7.5.9.3 Market size and forecast, distribution channel
7.5.10. Argentina
7.5.10.1 Market size and forecast, product type
7.5.10.2 Market size and forecast, application
7.5.10.3 Market size and forecast, distribution channel
7.5.11. Rest of LAMEA
7.5.11.1 Market size and forecast, product type
7.5.11.2 Market size and forecast, application
7.5.11.3 Market size and forecast, distribution channel

Chapter 8 : COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning,2022

Chapter 9 : COMPANY PROFILES
9.1. Teva Pharmaceutical Industries Ltd.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Nichi-Iko Pharmaceutical Co., Ltd.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Sawai Pharmaceuticals Co., Ltd.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. NIPRO Medical Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Meiji Seika Pharma Co., Ltd.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Towa Pharmaceutical Co., Ltd.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Hikari Pharmaceutical Co., Ltd.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Fuji Pharma Co., Ltd.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Mylan N.V.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. GlaxoSmithKline Plc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments